Full Text View
Tabular View
No Study Results Posted
Related Studies
The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study
This study has been completed.
Study NCT00206557   Information provided by The Alfred
First Received: September 13, 2005   Last Updated: April 20, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorder
Additional conditions recognized in this trial
Disease
Psychotic Disorders
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Raloxifene
Estradiol/dyhydroprogestrone
Additional drug interventions recognized in this trial
Estrogen Receptor Modulators
Estrogens
Selective Estrogen Receptor Modulators
More general drug interventions related to this trial
Bone Density Conservation Agents
Estrogen Antagonists
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
The Alfred
Stanley Medical Research Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services